Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.00p -1.35% 365.00p 360.00p 370.00p 370.00p 365.00p 370.00p 11,742 08:07:21
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 67.2 13.9 14.2 25.7 244.99

Eco Animal Health Share Discussion Threads

Showing 526 to 548 of 1025 messages
Chat Pages: Latest  29  28  27  26  25  24  23  22  21  20  19  18  Older
DateSubjectAuthorDiscuss
27/7/2015
20:41
More large volume today, definitely think this on the radar of larger boys nowadays
smelleroo
27/7/2015
09:20
indeed........v interesting times here.
smelleroo
24/7/2015
11:42
I think Merck use to be in animal healthcare as it was they who developed/invented the mectins which EAH sell as a generic. I held Dechra a few years back buying in at around 300p and selling at 600 which I think was before they acquired Vet XX. I regret selling them too soon but at the time I thought they had over-stretched themselves. That said, I doubled my money so can have no complaints. In many respects I face the same dilemma now with EAH as I have just about doubled what I have invested. Whilst I am tempted to sell some i see plenty more upside to come as they grow the business. And of course there is the expectation they will be acquired at a significant premium to today's share price I guess there are a host of potential buyers but whoever it is I'm sure that Peter Lawrence will want to endure the future of his current employees who have worked very hard to make the company successful. For that reason I think a large U.S. Corporate will not be as favoured as an EU based company. Whoever it is will need to already be in the farm animal market and have a well established distribution network. The kind if business model EAH have brings with it very complicated supply logistics and consequently relatively costly. So I think it has to be another company that already has this infrastructure in place in the key markets for EAH.
audigger
24/7/2015
10:41
Read somewhere that Merck were wanting to move into animal healthcare! Any views on Dechra they also look interesting.
winston8643
24/7/2015
06:42
And another nudge up yday
smelleroo
21/7/2015
07:43
so share price moved up yday, could Friday's business in EAH have cleared up the mgmt options and any loose holders........eah is growing in size, could well be falling on the radar of some of the larger sized investors......
smelleroo
17/7/2015
12:36
and some BIG business in eah........be interesting to see how this trades now
smelleroo
16/7/2015
10:46
looks like biz on Monday, has cleared things up here now.......onwards and upwards!
smelleroo
16/7/2015
09:43
SP is oscillating a bit.....nice to see it back in the blue again.
audigger
06/7/2015
08:13
Can't see a North American listing. Peter Lawrence will sell when he is ready, I guess. He is nearly 70 so can see this getting sold at anytime when the offer is attractive enough but probably in a 1-3 year timescale?
topvest
05/7/2015
15:17
What about a North American listing For eah?
smelleroo
05/7/2015
12:21
" The PER looks to be up with events though." Yes, it does, but the company has spent heavily on research and on registratration costs over a number of years and is now beginning to reap the rewards. There should be good growth in sales and profits over several years, especially with the large American market now coming on stream, and in due course it is likely to taken over by a bigger group in whose hands, with their own sales forces instead of agents, it will be even more profitable. The shares are tightly held and the downside risk seems minimal to me.
aimingupward2
05/7/2015
11:08
Taking a look here as the hound and I think it a great sector to be in right now. The PER looks to be up with events though.
pet lover
05/7/2015
09:02
Valuation is always tricky here with drug registration costs still impacting results. Gross margins at 45%, whilst high, would no doubt be much higher if owned by a global pharma company. Not really sure how to value this one, but happy to hold now that the revenue growth is starting to accelerate. It's been a long time coming!
topvest
03/7/2015
09:36
Why, I wonder, are we getting a second interim and not a final dividend? Does this imply that a final divi might yet be announced later?
aimingupward2
03/7/2015
09:10
And it is exactly that exit strategy that should see holders reap handsome rewards. share price now flat after initial 7p rise.......AIM shares for you, although there has been a big increase prior to results so it is likely priced in. Next interims will be interesting especially if there is a further jump in sales/profits.
audigger
03/7/2015
08:38
Looks like there's a really good period ahead wth rapidly increasing sales and profits. I suppose that in due time Peter Lawrence may look to selling EAH out to a larger company, with their own sales forces, in whose hands it will be even more profitable and valuable, compared to EAH now who largely use agents.
aimingupward2
03/7/2015
07:23
indeed - big opportunities in N. America and SE Asia both VERY big regions!!
smelleroo
03/7/2015
07:08
What an impressive set of results! And they even have the confidence to say up- front that the next set of interims will also be good.
audigger
30/6/2015
07:48
results on Friday .
winston8643
18/6/2015
20:52
well company have been buying back shares so they believe it is cheap. results just around the corner, beginning of july. not on many's radar, cannot help will get taken-out going forward given what has been created!
smelleroo
18/6/2015
12:06
this stock seems very cheap am i missing something, may be the MM's are short and we wont rally until they get some stock .
winston8643
08/6/2015
09:49
Correction, we have actually hit 300.....
audigger
Chat Pages: Latest  29  28  27  26  25  24  23  22  21  20  19  18  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190524 04:06:15